Reversing the aging stromal phenotype prevents carcinoma initiation

Aging

Volumn 3, Issue 4, 2011, Pages 407-416

  Lewis, Davina A ^a   Travers, Jeffrey B ^a   Machado, Christiane ^a   Somani, Ally Khan ^a   Spandau, Dan F ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Photocarcinogenesis; Senescence; Therapy; UVB

Indexed keywords

BIOLOGICAL MARKER; SOMATOMEDIN C;

AGED; ARTICLE; CELL AGING; CYTOLOGY; DNA DAMAGE; EPITHELIUM CELL; FIBROBLAST; HUMAN; KERATINOCYTE; METABOLISM; MIDDLE AGED; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; RADIATION EXPOSURE; SKIN; SKIN ABRASION; STROMA CELL; WOUND HEALING;

AGED; BIOLOGICAL MARKERS; CELL AGING; DERMABRASION; DNA DAMAGE; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; MIDDLE AGED; NEOPLASMS; PHENOTYPE; SKIN; STROMAL CELLS; WOUND HEALING;

EID: 80052093232     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100318     Document Type: Article

References (50)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. the global picture. Euro J Cancer 2001; 37: S4-S66.
2. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescenceassociated secretory phenotype: the dark side of tumor suppression. Ann Rev Path Mech Dis 2010; 5: 99-118.
3. Lewis DA, Travers JB, Somani AK, Spandau DF. The IGF-1/IGF- 1R signaling axis in the skin: a new role for the dermis in agingassociated skin cancer. Oncogene 2010; 29: 1475-1485.
4. Anisimov VN. Carcinogenesis and aging 20 years after: escaping horizon. Mech of Ageing Develop 2009; 130: 105-121.
5. Lewis DA, Travers JB, Spandau DF. A new paradigm for the role of aging in the development of skin cancer. J Invest Dermatol 2008; 129: 787-791.
6. Lewis DA, Travers JB, Spandau DF. (2010) Aging-associated non-melanoma skin cancer: a role for the dermis. In Textbook of Aging Skin, MA Farage, KW Miller and HI Maibach, eds. (Springer Berlin Heidelberg), pp 588-599.
7. Chuang T-Y, Lewis DA, Spandau DF. Decreased incidence of non-melanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study. Br J Dermatol 2005; 153: 552-557.
8. Kuhn C, Kumar M, Hurwitz SA, Cotton J, Spandau DF. Activation of the insulin-like growth factor-1 receptor promotes the survival of human keratinocytes following ultraviolet B irradiation. Intl J Cancer 1999; 80: 431-438.
9. Lewis DA, Spandau DF. UVB-induced activation of NF-?B is regulated by the IGF-1R and dependent on p38 MAPK. J Invest Dermatol 2008; 128: 1022-1029.
10. Lewis DA, Yi Q, Travers JB, Spandau DF. UVB-induced senescence in human keratinocytes requires a functional IGF-1R and p53. Mol Biol Cell 2008; 19:1346-1353.
11. American Cancer Society. Cancer Facts and Figures 2010. www.cancer.org/downloads/STT/Cancer_Facts_and_Figures_2010.pdf
12. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146: 283-287.
13. Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E, et. al. The burden of skin diseases. J Am Acad Dermatol 2006; 55: 490-500.
14. Housman TS, Feldman SR, Williford PM, Fleischer AB, Goldman ND, Acostamadiedo JM, et. al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003; 48: 425-429.
15. Kraemer KH. Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci USA 1997; 94: 11-14.
16. National Institutes of Health, Sun Protection in Cancer Trends Progress Report - 2009/2010, www.cancer.gov
17. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor progression. J Invest Dermatol Symp Proc 1996; 1: 136-142.
18. Jeffes EWB, Tang EH: Actinic keratosis: current treatment options. Am J Clin Dermatol 2000; 1: 167-179.
19. Godar DE, Urbach F, Gasparro FP, van der Leun JC. UV doses of young adults. Photochem. Photobiol. 2003; 77: 453-457.
20. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nature Med 2004; 10: 789-799.
21. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et. al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314: 268-274.
22. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc Natl Acad Sci USA 2001: 98: 12072-12077.
23. Parrinello S, Coppe J-P, Krtolica A, Campisi J. Stromalepithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 2005; 118: 485-496.
24. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120: 513-522.
25. Campisi J. Suppressing cancer: the importance of being senescent. Science 2005; 309: 886-887.
26. Dimri GP. What has senescence got to do with cancer? Cancer Cell 2005; 7: 505-512.
27. Feng Z, Hu W, Teresky AK, Hernando E, Cordon-Dardo C, Levine AJ. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci USA 2007; 104: 16633-16638.
28. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelly C, et. al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-9367.
29. d'Adda di Fagagna, F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 2008; 8: 512-522.
30. Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8: 4112-4118.
31. Seviour EG, Lin SY. The DNA damage response: balancing the scale between cancer and ageing. Aging 2010; 2: 900-907.
32. Redon CE, Nakamura AJ, Martin OA, Parekh PR, Weyemi US, Bonner WM. Recent developments in the use of ?-H2AX as a quantitative DNA double-strand break biomarker. Aging 2011, 3: 168-174.
33. Makrantonaki E, Zouboulis CC. (2010). Pathomechanisms of endogenously aged skin. In Textbook of Aging Skin, MA Farage, KW Miller and HI Maibach, eds. (Springer Berlin Heidelberg), pp 93-99.
34. Ramos-e-Silva M, da Silva Carneiro SC. Elderly skin and its rejuvenation: products and procedures for the aging skin. J Cosmetic Dermatol 2007; 6: 40-50.
35. Helmbold P. (2010). Basophilic (actinic) degeneration of the dermis: an easy histological scoring approach in dermal photoaging. In Textbook of Aging Skin, MA Farage, KW Miller and HI Maibach, eds. (Springer Berlin Heidelberg), pp 19-21.
36. Farage MA, Miller KW, Maibach HI. (2010). Degenerative changes in aging skin. In Textbook of Aging Skin, MA Farage, KW Miller and HI Maibach, eds. (Springer Berlin Heidelberg), pp 25-35.
37. Mine S, Fortunel NO, Pageon H, Asselineau D. Aging alters functionally human dermal papillary fibroblasts but not reticular fibroblasts: a view of skin morphogenesis and aging. PLoS ONE 2008; 3: e4066 (1-13).
38. Fisher GJ, Varani J, Voorhees JJ. Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol 2008; 144: 666-672.
39. Lawrence N, Mandy S, Yarborough J, Alt T. History of dermabrasion. Dermatol Surg 2000; 26: 95-101.
40. Friedman S, Lippitz J. Chemical peels, dermabrasion, and laser therapy. Dis Mon 2009; 55: 223-235.
41. Epstein, E. Planing for precancerous skin: a ten-year evaluation. California Med 1966; 105: 26-27.
42. Benedetto AV, Griffin TD, Benedetto EA, Humeniuk HM. Dermabrasion: therapy and prophylaxis of the photoaged face. J Am Acad Dermatol 1992; 27: 439-447.
43. Coleman WP, Yarborough JM, Mandy SH. Dermabrasion for prophylaxis and treatment of actinic keratoses. Dermatol Surg 1996; 22: 17-21.
44. Field LM. Dermabrasion and premalignant disease. Dermatol Surg 1997; 23: 714.
45. Cooley JE, Casey DL, Kauffman CL. Manual resurfacing and trichloracetic acid for the treatment of patients with widespread actinic damage. Dermatol Surg 1997; 23: 373-379.
46. Hantash BM, Stewart DB, Cooper ZA, Rehmus WE, Koch RJ, Swetter SM. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol 2006; 142: 976-982.
47. Ostertag JU, Quaedvlieg PJF, Neumann MHAM, Kerkels GA. Recurrence rates and long-term follow-up after laser resurfacing as a treatment for widespread actinic keratoses in the face and on the scalp. Dermatol Surg 2006; 32: 261-267.
48. Halachmi S, Lapidoth M. Lasers in skin cancer prophylaxis. Exp Rev Anticancer Therapy 2008; 8: 1713-1715.
49. Love WE, Bernhard JD, Bordeaux JS. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma. Arch Dermatol 2009; 145: 1431-1438.
50. Field LM. The superiority of dermabrasion over laser abrasion in the prophylaxis of malignant and premalignant disease. Dermatol Surg 2007; 33: 258-259.